4//SEC Filing
THANGARAJ IMMANUEL 4
Accession 0001104659-20-002280
CIK 0000786947other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:31 PM ET
Size
11.5 KB
Accession
0001104659-20-002280
Insider Transaction Report
Form 4
THANGARAJ IMMANUEL
Director
Transactions
- Exercise/Conversion
Common Stock
2020-01-02+83,333→ 209,525 total - Exercise/Conversion
Restricted Stock Units (2017 Plan)
2020-01-02−83,333→ 0 total→ Common Stock (83,333 underlying) - Award
Restricted Stock Units (2017 Plan)
2020-01-02+54,790→ 54,790 total→ Common Stock (54,790 underlying)
Holdings
- 1,956,396(indirect: By Essex Woodlands Health Venture Fund V, L.P.)
Common Stock
Footnotes (8)
- [F1]Represents exchange of restricted stock units.
- [F2]Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
- [F3]Does not include Restricted Stock Units.
- [F4]1 - for - 1
- [F5]83,333 Restricted Stock Units were granted on the first business day of January 2019. 25% of Restricted Stock Units vested on March 31, 2019, 25% vested on June 30, 2019; 25% vested on September 30, 2019 and 25% vested on December 31, 2019. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
- [F6]N/A
- [F7]25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2020, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2021, or earlier upon a change of control.
- [F8]The reporting person is a managing director of the general partner of Essex Woodlands Health Ventures Fund V, L.P. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
Related Parties
1- filerCIK 0001213308
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:31 PM ET
- Size
- 11.5 KB